Hematoxylin and Eosin Staining Kit: Workflow
2026-08-29
The Hematoxylin and Eosin Staining Kit (SKU K1142) provides ready-to-use hematoxylin and eosin solutions for visualizing nuclei, cytoplasm, extracellular matrix, and overall tissue architecture. It is intended for research workflows involving paraffin-embedded or frozen sections and cytological preparations, not for diagnosis or medical decision-making.
Rotigotine Analytical Methods and Impurity Control
2026-08-29
This review consolidates chromatographic and related analytical methods for rotigotine in raw materials and transdermal formulations, with particular attention to degradation products and chiral purity. Its main practical contribution is a framework for connecting assay specificity, impurity profiling, formulation stability, and quality control, while highlighting gaps in the toxicological and pharmacokinetic characterization of impurities.
Lumiracoxib in COX-2 Pathway Research
2026-08-28
Lumiracoxib enables selective interrogation of COX-2 signaling in prostaglandin, inflammation, ischemia, and revascularization models. Its greatest value is temporal: the same inhibitor can reveal different biology when applied during acute injury versus later tissue remodeling.
One-step TUNEL FITC Apoptosis Detection Kit Guide
2026-08-28
The One-step TUNEL FITC Apoptosis Detection Kit provides a practical DNA fragmentation assay for tissue sections and cultured cells. This guide connects TUNEL signal interpretation with a neonatal neurotoxicity study, helping researchers design more rigorous apoptosis experiments.
FASN, Mitochondrial Priming, and ABT-263
2026-08-27
The reference study identifies fatty acid synthase (FASN) as a metabolic regulator of mitochondrial apoptotic priming, not merely a source of tumor-building lipids. Its findings show that FASN inhibition increases dependence on anti-apoptotic BCL-2 signaling and can markedly improve responses to BH3 mimetics in breast cancer models.
Drug Response Metrics in Cancer Cell Models
2026-08-27
Hannah R. Schwartz’s dissertation distinguishes relative viability from fractional viability, showing that growth inhibition and cell death are related but noninterchangeable drug-response outcomes. The framework supports more informative in vitro cancer studies by combining endpoint definitions with time-resolved, death-specific measurements.
Angiotensin II: From Pressure to Atrial Remodeling
2026-08-26
A translational guide to using Angiotensin II to connect GPCR signaling, oxidative stress, DNA damage, and cardiovascular remodeling, with practical design considerations for cell and animal studies.
Baicalin Methyl Ester for Intestinal Barrier Research
2026-08-26
Baicalin methyl ester is an esterified derivative of baicalin with reported activity in LPS-induced intestinal barrier damage models. Product-dossier data connect the compound with P65/TNF-α/MLCK/ZO-1 signaling, cytokine regulation, tight-junction restoration, and defined research-use concentration ranges.
NADH Workflows for Redox and Mitochondrial Research
2026-08-25
Build reproducible NADH assays for cellular energy metabolism, mitochondrial electron transport chain research, disease modeling, and photocatalytic cancer therapy. This workflow-oriented guide connects controlled reagent handling with ratio-based readouts, light-dependent controls, and practical troubleshooting.
ATP Solution for p21 mRNA Workflows
2026-08-25
A high-purity 100 mM ATP stock can strengthen the upstream transcription, ligation, kinase, and phosphorylation steps that support p21 mRNA–LNP research. This guide translates the bladder cancer study into practical assay design, dosing controls, and troubleshooting decisions without confusing an enabling reagent with the therapeutic formulation itself.
Dopamine Inhibits Osteoclastogenesis via cAMP/PKA/CREB
2026-08-24
Wang et al. identify a D2 receptor–cAMP/PKA/CREB axis through which dopamine suppresses osteoclast differentiation in a RAW-cell model. Their pharmacological rescue experiments place CREB downstream of cAMP and PKA, providing a mechanistic framework for studying neural regulation of bone remodeling.
3-Deazaadenosine hydrochloride in m6A Studies
2026-08-23
Use 3-Deazaadenosine hydrochloride to perturb SAHH-dependent methyl metabolism while dissecting the IGF2BP1–TUBB4B pathway in hepatic stellate cells. This workflow combines pathway-level pharmacology with RNA, protein, proliferation, and migration readouts to distinguish methylation effects from nonspecific cytotoxicity.
EZ Cap™ Cy5 EGFP mRNA (5-moUTP) Workflow
2026-08-22
Build a dual-readout mRNA delivery workflow that separates cellular uptake from productive translation. EZ Cap™ Cy5 EGFP mRNA (5-moUTP) supports nanoparticle screening, macrophage-targeted studies, and quantitative optimization with direct Cy5 tracking plus EGFP function.
Cy3 Goat Anti-Mouse IgG (H+L) Antibody Workflow
2026-08-21
Build a high-contrast fluorescence workflow for mapping mouse primary antibodies in NCI-H295R endocrine-cell studies and related immunoassays. This guide connects Cy3 signal amplification with renalase–PMCA4b–cAMP research while providing practical starting conditions for immunofluorescence, flow cytometry, western blotting, and tissue staining.
L-Threonine: Linking Metabolism to Smarter ALP Assays
2026-08-21
L-Threonine is more than a nutritional substrate: it is a controllable variable in cell culture optimization, metabolic profiling, and enzyme-readout design. This article explains how its metabolic context can be integrated with a metal-free nanozyme ALP assay without confusing nutrient effects with direct enzyme inhibition.
461 records 7/31 page Previous Next First page 上5页 678910 下5页 Last page